Active, human recombinant enzyme purified from E. coli
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

USP2 active domain (human recombinant)

Item No. 22784

Technical Information
Synonyms
  • Ubiquitin C-terminal Hydrolase 2
  • Ubiquitin-specific Protease 2
Purity
≥95% estimated by SDS-PAGE
Source
C-terminally Histidine-tagged human USP2 enzyme (active catalytic domain) purified from E. coli
Amino Acids
259-605 (active catalytic domain)
MW
40.9 kDa
50 mM HEPES, pH 8.0, 150 mM sodium chloride, 1 mM DTT, and 0.1 mM EDTA
UniProt Accession №
O75604
Shipping & Storage Information
Storage
-80°C
Shipping
Dry ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Ubiquitin-specific protease 2 (USP2), also known as ubiquitin carboxyl-terminal hydrolase 2, is a cysteine protease involved in intracellular protein degradation by deubiquitinating degraded protein, including Mdm2, Mdm4, and CCND1.1,2,3 In both normal and cancer cells, it regulates G1/S cell-cycle transition.2 It may regulate p53-dependent pathways by deubiquitinating Mdm2, indirectly promoting p53 degradation and limiting its activity.1,4,5. Regulated by androgen, USP2 is over-expressed in prostate cancer and stabilizes fatty acid synthase (FASN), which is associated with the malignancy of some aggressive prostate cancers.4,6 Some of these oncogenic properties may be linked to its deubiquitinating activity. One hypothesis is that USP2 may stabilize short-lived proteins that may act to induce apoptosis.7 USP2 has also been shown to regulate the intrinsic circadian rhythm and its capacity to respond to external cues, in a non-degradative manner by acting on the core clock component PER1.8 This protein is a truncation containing the active catalytic domain (residues 259-605) of USP2 and a C-terminal His-tag.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Stevenson, L.F., Sparks, A.A., Allende-Vega, N., et alThe deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2. EMBO J. 26(4), 976-986 (2007).

    2. Shan, J., Zhao, W., and Gu, W. Suppression of cancer cell growth by promoting cyclin D1 degradation. Mol. Cell. 36(3), 469-476 (2009).

    3. Allende-Vega, N., Sparks, A., Lane, D.P., et alMdmX is a substrate for the deubiquitinating enzyme USP2a. Oncogene 29(3), 432-441 (2010).

    4. Priolo, C., Tang, D., Brahamandan, M., et alThe isopeptidase USP2a protects human prostate cancer from apoptosis. Cancer Res. 66(17), 8625-8632 (2006).

    5. Renatus, M., Parrado, S.G., D'Arcy, A., et alStructural basis of ubiquitin recognition by the deubiquitinating protease USP2. Structure 14(8), 1293-1302 (2006).

    6. Graner, E., Tang, D., Rossi, S., et alThe isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer. Cancer Cell 593), 253-261 (2004).

    7. Gewies, A., and Grimm, S. UBP41 is a proapoptotic ubiquitin-specific protease. Cancer Res. 63(3), 682-688 (2003).

    8. Stojkovic, K., Wing, S., and Cermakian, N. A central role for ubiquitination within a circadian clock protein modification code. Front. Mol. Neurosci. 7(69), (2014).